It is telling that after more than 20 years in contingent workforce management, Meg Ksenzakovic finds joy in experiencing new challenges. She is also grateful for all the experienced hands that have helped her through the staffing ecosystem and the opportunities she has had to make a positive impact — most recently as the current director of the global contingent workforce at Bristol Myers Squibb.

Since the Covid-19 pandemic began, Ksenzakovic has had to navigate new challenges. In 2021, she and her team expanded their contingent workforce to the United Kingdom and the work that would have normally been completed in person was adapted to be completed remotely. The program implementation required many hands on deck. Partnership was pivotal in introducing the new culture and program as well as adapting the rules and guidelines to the local geography. “I was really lucky to benefit from years of experience and learning in the staffing industry and from others as well as my internal partners. You have to put your ears to the ground to support the geography that you are in – which can be hard to do from across the pond,” says Ksenzakovic of the experience.

She feels fortunate to work for a biopharmaceutical company, “We are committed to innovation and strategy. Currently, one of the key initiatives we are focused on supporting is our cell therapy business, which is a space that is new and so fascinating,” Ksenzakovic explains.  She adds that they need people in this evolving field at every level and finding the right people to succeed in this space is constantly evolving.  It’s an exciting time for Ksenzakovic and her team.  “Everything that we are doing – even in our contingent workforce program – is with the end goal of helping our patients.”